The goal of this implementation trial is to learn if providing education to doctors and patients who have had a heart event works to prevent future heart probl…

ASCVDLDL-C

~Estimated

~$10 – $6,250

Duke UniversityNCT06471036

Phase 4

Study of Optimal LDL-C Value Enhancement With Inclisiran in Patients With Multiple Comorbidities in Which There Are Drug-Drug Interactions Limiting LDL-C Lowering

Drug-drug interactions often limit statin optimization in a population of patients prescribed cytochrome P3A4 inhibitors, which include immunosuppressive agent…

Drug InteractionsPrimary PreventionCardiometabolic Syndrome+1 more

~Estimated

~$10 – $6,250

University of California, San DiegoNCT06865885

Observational

Corrie Lipids Program: Optimizing LDL-Cholesterol by Improving Awareness, Access, and Achievement

The overall objective is to evaluate the effectiveness and implementation of the Corrie Lipids Program, a comprehensive digital health initiative designed to a…

Cardiovascular RiskLDL-CLipids+2 more

~Estimated

~$10 – $6,250

Johns Hopkins UniversityNCT07478887